Delivery Order SPE2DX22D0129-SPE2D826F0APT

This delivery order, awarded October 20, 2025, represents a $107,300.80 firm fixed price contract issued by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vehicle enables the company to supply comprehensive pharmaceutical products and medical commodities to support military healthcare programs globally, including medications, vaccines, medical devices, and specialized healthcare supplies across multiple therapeutic domains. The award carries no set-aside designation and was competitively awarded through open competition.

The delivery order is scheduled for completion by October 21, 2025, with performance to be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a critical vendor within the Defense Health Agency's pharmaceutical supply network, AmerisourceBergen demonstrates substantial capability in fulfilling federal medical procurement requirements, with a demonstrated portfolio spanning brand-name and generic medications, specialty pharmaceuticals, and medical supplies. The DLA Medical Supply Chain is transitioning to a new Pharmaceutical Prime Vendor Global Program Generation V structure, which will involve multiple regional awards to different contractors, positioning this delivery order within the agency's broader strategic modernization of pharmaceutical distribution capabilities.